Assessment methods for immune status include immune scoring (evaluating CD3+ and CD8+ T-cell density and distribution), PD-L1 expression analysis, TMB measurement, cytokine profiling (e.g., interferon-γ, interleukins, TNF), and detection of tumor-infiltrating lymphocytes (TILs) [2]. The gene discussed is CD274; the disease is neoplasm.